Ajooni Biotech files regulatory certificate for Q2 2026
Ajooni Biotech files regulatory compliance certificate for Q2 2026. The company submitted the confirmation certificate as per SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance requirement with no direct financial impact.
📊 STOCKS: $AJOONIBIO | 🏢 SECTOR: Pharma | #LOWIMPACT #RegulatoryFiling
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.